SUPN icon

Supernus Pharmaceuticals
SUPN

Overview Fund Activity

245 hedge funds and large institutions have $1.67B invested in Supernus Pharmaceuticals in 2023 Q4 according to their latest regulatory filings, with 32 funds opening new positions, 85 increasing their positions, 89 reducing their positions, and 21 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
245
Holders Change
+8
Holders Change %
+3.38%
% of All Funds
3.59%
Holding in Top 10
2
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-33.33%
% of All Funds
0.03%
New
32
Increased
85
Reduced
89
Closed
21
Calls
$766K
Puts
$778K
Net Calls
-$12K
Net Calls Change
-$571K

Top Buyers

1
Morgan Stanley
Morgan Stanley
New York
$41.9M
2
Schroder Investment Management Group
Schroder Investment Management Group
United Kingdom
$15.7M
3
PCH
Polar Capital Holdings
United Kingdom
$56.1M
4
BlackRock
BlackRock
New York
$300M
5
SIMG
Stephens Investment Management Group
Texas
$55.1M

Top Sellers

1
BG
Bellevue Group
Switzerland
$437K
2
AC
Armistice Capital
New York
$135M
3
IHAM
Integral Health Asset Management
New York
$0
4
FCM
Frontier Capital Management
Massachusetts
$0
5
Citadel Advisors
Citadel Advisors
Florida
$6.08M
Name Holding Trade Value Shares
Change 		Shares
Change %
BlackRock
1
BlackRock
New York
$300M +$5.87M +202,865 +2%
Vanguard Group
2
Vanguard Group
Pennsylvania
$180M +$4.13M +142,551 +2%
AC
3
Armistice Capital
New York
$135M -$12.8M -442,000 -9%
Macquarie Group
4
Macquarie Group
Australia
$79.2M -$380K -13,140 -0.5%
Dimensional Fund Advisors
5
Dimensional Fund Advisors
Texas
$71.1M +$4.1M +141,586 +6%
State Street
6
State Street
Massachusetts
$59.7M +$4.21M +145,316 +8%
PCH
7
Polar Capital Holdings
United Kingdom
$56.1M +$8.24M +284,895 +17%
SIMG
8
Stephens Investment Management Group
Texas
$55.1M +$5.79M +200,166 +12%
Loomis, Sayles & Company
9
Loomis, Sayles & Company
Massachusetts
$47.4M -$2.71M -93,779 -5%
Morgan Stanley
10
Morgan Stanley
New York
$41.9M +$26.6M +918,131 +174%
Renaissance Technologies
11
Renaissance Technologies
New York
$39.9M -$1.74M -60,000 -4%
GKIM
12
GW&K Investment Management
Massachusetts
$38.1M -$2.56M -88,632 -6%
Geode Capital Management
13
Geode Capital Management
Massachusetts
$36M +$4.4M +152,057 +14%
ACB
14
Aristotle Capital Boston
Massachusetts
$33.6M -$815K -28,153 -2%
Pictet Asset Management
15
Pictet Asset Management
Switzerland
$30.3M +$3.63M +125,530 +14%
CAM
16
Congress Asset Management
Massachusetts
$26.6M +$105K +3,644 +0.4%
ACM
17
Ashford Capital Management
Delaware
$23.9M -$2.61M -90,259 -10%
Victory Capital Management
18
Victory Capital Management
Texas
$20M -$601K -20,771 -3%
Northern Trust
19
Northern Trust
Illinois
$18.8M -$2.48M -85,704 -12%
Ameriprise
20
Ameriprise
Minnesota
$16.2M -$270K -9,317 -2%
Charles Schwab
21
Charles Schwab
California
$16.1M +$714K +24,684 +5%
Schroder Investment Management Group
22
Schroder Investment Management Group
United Kingdom
$15.7M +$15.7M +541,973 New
RHJA
23
Rice Hall James & Associates
California
$15.3M -$420K -14,516 -3%
Invesco
24
Invesco
Georgia
$15.3M -$4.42M -152,743 -22%
Bank of New York Mellon
25
Bank of New York Mellon
New York
$12.9M -$305K -10,555 -2%
1
2 3 4 5